intracellulartherapies.com (ITCI) - Dodolan perusahaan
Biopharmaceutical leader Intra-Cellular Therapies (ITCI) is generating a powerful cash flow driven by the success of Caplyta. The drug's unique safety profile allows the company to maintain premium pricing power, and the company's sales volume on GURU.Markets confirms this trend, where the parameter value reaches 0.68. Such growth is based on a sovereign development cycle, transforming the asset into a reliable defensive tool independent of macroeconomic conditions.
Rincian analitis perusahaan Intra-Cellular (ITCI)
- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator kapitalisasi pasar:
- data ekuitas miturut neraca:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Intra-Cellular Therapies|ITCI - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal intracellulartherapies.com|ITCI - Utang perusahaan|Rasio utang marang kapitalisasi buku Intra-Cellular Therapies Inc.|ITCI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Intra-Cellular Therapies|Rasio jangkoan perantara intracellulartherapies.com
- data bathi bisnis lan rasio investasi:
ITCI - Penghasilan resik|Penghasilan resik sing dikarepake Intra-Cellular Therapies|ITCI - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Intra-Cellular Therapies|ITCI - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Intra-Cellular Therapies Inc.|ITCI - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Intra-Cellular Therapies|ITCI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan intracellulartherapies.com|ITCI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Intra-Cellular Therapies
- indikator volume dodolan lan pendapatan:
Analisis komprehensif perusahaan:Intra-Cellular Therapies, Inc.
To separate fundamental stability from market noise, it is essential for investors to evaluate the aggregate cash flow from product sales, which measures the actual scale of the issuer's trading activity. By analyzing the sales revenue chart for Intra-Cellular Therapies (ITCI), one can confirm the effectiveness of the company's strategy to commercialize psychiatric drugs developed in close partnership with leading specialized clinics and medical experts.
Pesaing wigati
Volume dodolan perusahaan BIIB (Biogen)|Pendapatan perusahaan Neurocrine Biosciences, Inc. (NBIX)|Pendapatan perusahaan RGC (Regencell Bioscience Ltd)|Axsome Therapeutics, Inc. - Dodolan perusahaan|ACAD (ACADIA Pharmaceuticals Inc) - Pendapatan tahunan perusahaan|Xenon Corp - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan VKTX (Viking Therapeutics)|Supernus Pharmaceuticals (SUPN) - Pendapatan perusahaan|Pendapatan tahunan perusahaan CPRX (Catalyst Pharmaceuticals, Inc.)|Pendapatan perusahaan Denali Therapeutics Inc|Total pendapatan perusahaan Harmony Corp HRMY|Pendapatan lan volume dodolan BHVN|Dodolan perusahaan Amylyx Pharmaceuticals AMLX|Pendapatan lan volume dodolan TRVI (Trevi Corp)|Pendapatan reged perusahaan Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Pendapatan lan volume dodolan|CeriBell Corp (CBLL) - Dodolan perusahaan|Prothena Corp (PRTA) - Pendapatan perusahaan|Total pendapatan perusahaan Alector Inc. (ALEC)|Dodolan perusahaan ANNX|omeros.com (OMER) - Pendapatan reged perusahaan|Pendapatan perusahaan Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan VYGR (voyagertherapeutics.com)|Pendapatan reged perusahaan Neumora Therapeutics (NMRA)|SCLX - Pendapatan perusahaan|Total volume dodolan perusahaan Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Pendapatan perusahaan|CGTX - Pendapatan reged perusahaan|IKT (inhibikase.com) - Pendapatan lan volume dodolan|cassavasciences.com (SAVA) - Pendapatan reged perusahaan|Dodolan perusahaan ASRT (Assertio Therapeutics)|Pendapatan reged perusahaan Coya Therapeutics|Vistagen - Dodolan perusahaan|ovidrx.com (OVID) - Total pendapatan perusahaan|Acumen Pharmaceuticals - Pendapatan lan volume dodolan|Total pendapatan perusahaan cervomed.com|ATHE: Pendapatan lan volume dodolan|Clene Inc - Pendapatan dodolan perusahaan|Pendapatan perusahaan PepGen|JUNS (Jupiter Neurosciences Inc) - Total dodolan perusahaan|Dodolan perusahaan RLMD (Relmada Corp)|annovisbio.com - Volume dodolan perusahaan|Pendapatan perusahaan gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Pendapatan tahunan perusahaan|KLTO - Pendapatan perusahaan|Total pendapatan perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Pendapatan perusahaan|Volume dodolan perusahaan MTVA|Dodolan perusahaan NRXS|Dodolan perusahaan Helius Medical (HSDT)|Pendapatan lan volume dodolan PASG|Neuphoria Therapeutics - Volume dodolan perusahaan|Pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Pendapatan lan volume dodolan Athira Pharma ATHA|ADXN: Dodolan perusahaan|Total pendapatan perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Pendapatan perusahaan|Total pendapatan perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Pendapatan lan volume dodolan|Dodolan perusahaan Cortigent (CRGT)|Pendapatan lan volume dodolan ATXI|BCLI - Total pendapatan perusahaan|Pendapatan lan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Total pendapatan perusahaan|ELYM - Pendapatan perusahaan|LBPH: Pendapatan perusahaan|MRNS (Marinus Pharmaceuticals, Inc.) - Dodolan perusahaan|NKGen - Pendapatan dodolan perusahaan|Pendapatan perusahaan NeuroBo Pharmaceuticals, Inc.|Pendapatan lan volume dodolan Sage Therapeutics Inc|Pendapatan lan volume dodolan SNPX|TRVN - Total pendapatan perusahaan|Pendapatan perusahaan vigilneuro.com VIGL|Pendapatan reged perusahaan Anew Medical (WENA)|cerevel.com - Pendapatan lan volume dodolan
